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Optical density of bone repair 
after implantation of homogenous 
demineralized dentin matrix in diabetic 
rabbits
Abstract: This research evaluated the bone repair process after implan-
tation of homogenous demineralized dentin matrix (HDDM) in surgical 
defects in the parietal bone of rabbits with alloxan-induced diabetes, us-
ing a polytetrafluorethylene (PTFe) barrier for guided bone regeneration. 
Thirty-six rabbits were used and divided into four groups: control (C, 
n = 12), diabetic (D, n = 12, left parietal bone), diabetic with PTFe (D-
PTFe, same 12 rabbits, right parietal bone), and diabetic with PTFe asso-
ciated to HDDM (D-PTFe+HDDM, n = 12). Bone defects were created 
in the parietal bone of the rabbits and the experimental treatments were 
performed, where applicable. The rabbits were sacrificed after 15, 30, 60 
and 90 days. The bone defects were examined radiographically and by 
optical density (ANOVA and Tukey test, p < .05). The radiographic find-
ings showed that the D-PTFe+HDDM group presented greater radiopac-
ity and better trabecular bone arrangement when compared to that of 
the C, D and D-PTFe groups. The statistical analysis showed significant 
differences in the optical density of the newly formed bone among the 
studied groups. It was possible to conclude that HDDM was biocompat-
ible in diabetic rabbits. 
Descriptors: Dentin; Bone regeneration; Guided tissue regeneration; 
Bone density; Diabetes mellitus.
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Introduction
Recent studies have shown that homogeneous de-
mineralized dentin matrix (HDDM) slices stimulate 
new bone trabeculae formation, are incorporated 
into the surrounding bone tissue and are resorbed 
during the bone remodeling process.1-4
Diabetes mellitus is included in a group of meta-
bolic diseases that are characterized by hyperglyce-
mia. Diabetes mellitus has been related to long-term 
increase in blood glucose concentration. Glucose me-
tabolites are formed after many cell processes in the 
tissues. One class of irreversible molecules formed 
has been termed advanced glycosylation end-prod-
ucts (AGEs). AGEs cause qualitative and quantitative 
changes in extracellular matrix components such as 
collagen, proteoglycans, laminin, and vitronectin.5 
These changes in the extracellular matrix cause spe-
cific alterations in bone formation and bone remodel-
ing. Bone formation and bone mineral homeostasis 
have been shown to be reduced in experimental dia-
betic animals. Osseous turnover has also been shown 
to be depressed as measured by a decreased percent-
age of osteoclasts, osteoblasts, and osteoid formation, 
as well as a decrease in osteocalcin synthesis.6-8
The aim of this work was to evaluate the dynam-
ic process of bone repair after HDDM implantation 
in surgical bone defects created in the parietal bones 
of diabetic rabbits and occluded with polytetrafluor-
ethylene (PTFE) barrier.
Material and Methods
Thirty-six New Zealand adult rabbits with an 
average weight of 3.5 kg were divided into 4 groups: 
control (C), diabetic (D), diabetic with PTFe barrier 
(D-PTFe) and diabetic with PTFe barrier associated 
to HDDM (D-PTFe+HDDM). All animals received 
human care according to the National Research 
Council’s criteria and the study protocol had been 
previously approved by the Committee for Animal 
Use, School of Dentistry of São José dos Campos.
Diabetes was induced in rabbits by a single intra-
venous administration of alloxan monohydrate in the 
ear vein (dose 90 mg/kg) (Sigma Aldrich Chemical, 
Saint Louis, MO, USA). In this study, a blood glu-
cose level greater than 200 mg/dL indicated hyper-
glycemia. NPH Human Insulin (Humulin®N-100, 
Eli Lilly do Brasil Ltda., São Paulo, SP, Brazil), and 
Regular Human Insulin (Biohulin®R-100, BioBRÁS 
S.A., Belo Horizonte, MG, Brazil) were administered 
subcutaneously to the animals daily to maintain a 
stable serum glucose level between 200 mg/dL and 
350 mg/dL. The blood glucose level was monitored 
three times a day until sacrifice of all the animals.
HDDM was obtained by extraction of the central 
incisor of the rabbits in the control group and then 
prepared in slices, according to Gomes et al.3,4 (2001, 
2002) technique. The pulp tissue was totally removed 
by the apical foramina and the roots were scaled. 
After being washed with sterile physiologic serum at 
2°C, the teeth were immersed in a 0.6 N hydrochloric 
acid solution at 2°C, until complete demineralization. 
The specimens were then washed during 3 hours in 
distilled water under constant agitation, for total acid 
removal. The HDDM was cut into slices of approxi-
mately 8 µm in thickness with the aid of a freezing 
microtome (Model CTD, International-Harris Cryo-
stat, International Equipment Company, Needham 
heights, MA, USA). These slices were immersed in a 
special box filled with ethyl alcohol 70°/gentamicin 
(5 ml of alcohol per 0.2 ml of gentamicin) and stored 
at 2°C until the time of implantation.
Treatment protocol
The animals were anesthetized intramuscularly 
with 0.1 mg/dL of Rompum (Bayer, São Paulo, SP, 
Brazil), a pre-anesthetic solution, and 0.25 mg/dL of 
Ketalar (Holliday-Scott, São Paulo, SP, Brazil). An 
incision was made along the median sagittal plane of 
the head, followed by muscular dissection by planes, 
with incision of the periosteum. Subsequently, a sur-
gical bone defect was created in each parietal bone, 
with the aid of an 8.0 mm diameter trephine, and 
irrigated with 0.9% sterile saline solution. The bone 
defect had a circular form, with its depth equal to 
the thickness of the removed cortical bone. In the D-
PTFe+HDDM group, a PTFe barrier was positioned 
on the floor of the bone defect and HDDM was 
placed in slices, internally and peripherally to the 
same bone defect. The external surface of the bone 
defect was completely recovered by PTFe barrier. In 
the D-PTFe group, PTFe barrier was placed on the 
floor and on the surface of the surgical bone defect. 
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In the control and diabetic groups the bone defects 
were naturally fi lled with blood clot. Subsequently, 
the periosteum and muscle were sutured, as well as 
the skin. The animals were treated with an intra-
muscular injection of benzylpenicillin (24.000 UI/
kg), streptomycin (10 mg/kg) and dihydrostrep-
tomycin (10 mg/kg) (Pentabiótico®; Fort Dodge 
Saúde Animal, São Paulo, SP, Brazil) after surgery 
and with 2.8 mg/kg of Celecoxib, (Celebra®, Pfi zer 
Pharmacia, São Paulo, SP, Brazil) during 5 days after 
surgery. Fifteen, 30, 60 and 90 days after surgery, 
3 animals of each group were sacrifi ced. The bone 
containing the surgical defect was removed in block, 
fi xed in 10% formalin during 72 hours, and submit-
ted to digital radiographic examination.
Optical density and statistical analysis
To obtain digital radiographic images of the spec-
imens, a sensor type image plate (Charge-Coupled 
Device, Trophy Radiologie, Vincennes, France) was 
utilized and the radiographs were exposed at a 40-
cm ffd (fi xed focal distance), 7 mAs, and 65 kVp. The 
sensor plate images were read by the software VixWin 
1.9 (Gendex Dental System, Dentsply International, 
Chicago, IL, USA) and these images were transferred 
to a computer according to bone density features. The 
measurements of these digital images were performed 
by another software (Kodak, Aldus Photo Styler 2.0) 
which enabled mensuration of 256 grayscale levels. 
The optical density results were submitted to analysis 
of variance (ANOVA) and the Tukey test. The level of 
signifi cance used was p < 0.05.
Results
Radiographic features
Defect at 15 days
In the control group, the topography of the de-
fects was well defi ned, and their limits were irregu-
lar (Figure 1A). In the diabetic group, radiolucent 
images were observed in the bone defect area show-
ing well defi ned limits, with higher optical intensity 
when compared with that of the other groups. In 
some regions, a discrete radiopaque area was ob-
served over the walls of the defect (Figure 1B). In 
the PTFe-diabetic group, the defects exhibited ra-
diolucent images with smooth as well as irregular 
limits. The radiopaque areas over the defect walls 
were more widespread and homogeneous when com-
pared with that of the other groups (Figure 1C). The 
D-HDDM+PTFe group showed an accentuated in-
crease of radiopacity in the region of the defect. The 
radiographic intensity was discretely similar to that 
of the radiopaque images of the surrounding normal 
bone tissue (Figure 1D).
Defect at 30 days
In the control group, the defect region was not 
well defi ned and also had irregular limits. The ra-
diopaque areas fi lling the central portion of the 
defects were discretely radiolucent, with irregular 
size and shape next to the bone defect walls. In 
the diabetic group the topography of the surgical 
defect still showed irregular limits and signifi cant 
predominance of radiolucent areas. In the PTFe-
diabetic group, the bone defect topography was 
A B C D
Figure 1 - Digital radiographic images of bone defect in the parietal bone of rabbit taken at 15 days: (A) control group; (B) 
diabetic group presenting radiopaque areas next to the defect walls (dotted arrow); (C) diabetic-PTFe group presenting extensive, 
homogeneous and radiopaque areas (continuous arrow); (D) diabetic-PTFe+ HDDM group.
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poorly expressed, with imprecise and irregular 
limits. It was more radiopaque in the peripheral 
region than in the central region of the surgical de-
fect. This radiopacity was similar to that of nor-
mal bone. In the diabetic-PTFe group + HDDM, 
the defect presented a radiopaque image, with less 
intensity in comparison to that of the surrounding 
normal bone. These images were homogeneous in 
the periphery and heterogeneous in the central por-
tion of the defect.
Defect at 60 days
In the control group, the bone defects were poor-
ly defi ned. In some regions the limits of their walls 
could be observed, although there was evidence of 
increasing radiopacity in the limits of the surgical 
defect. In the diabetic group, the bone defect to-
pography was well evidenced, but the pattern of the 
walls was imprecise and irregular when compared 
with those of the previous observation times. In the 
diabetic-PTFe group, the bone defect topography 
was poorly evidenced and its walls were imprecise 
and irregular. It was observed that there was a grad-
ual increase of radiopacity in the central portion of 
the defect, but with less intensity when compared 
with the control group. In the diabetic-PTFe group + 
HDDM, a shadow was observed at the limits of the 
previous surgical defects; however, an homogeneous 
radiopacity was present in the other areas of the de-
fect. The radiopacity of the central portion of the 
defect presented less intensity when compared with 
the normal surrounding bone tissue.
Defect at 90 days
In the control group, the radiolucent image cor-
responding to the defect remained evident, but was 
more discrete when compared with the previous pe-
riods of time (Figure 2A). In the diabetic group, the 
bone defect topography could still be observed and its 
walls were more imprecise and irregular when com-
pared with the previous observation times of the same 
groups. The central portion of the defect presented an 
extensive radiolucent area when compared with the 
other studied groups (Figure 2B). In the diabetic-PTFe 
group, the bone defect topography could not be seen 
anymore, and there was a higher radiopacity area in 
the peripheral region than in the central region result-
ing from centripetal growth during the bone repair 
process. There was a gradual increase of radiopacity 
in the entire extension of the defect when compared 
to the control and diabetic groups (Figure 2C). In the 
diabetic-PTFe+HDDM group, the region of the bone 
defect was totally replaced by a radiopaque image, 
with areas presenting higher optical intensity when 
compared to that of the normal surrounding bone. 
In some areas, radiopaque lines were observed inter-
mixed in the region of the defect, probably character-
izing a disorganized arrangement of bone trabeculae 
formed during the repair process (Figure 2D).
Optical density and statistical analysis
The purpose of the densitometric analysis was 
to measure the optical density of newly formed 
bone matrix in the bone defects of the experimental 
groups, providing the necessary data for statistical 
A B C D
Figure 2 - Digital radiographic images of bone defect in the parietal bone of rabbit taken at 90 days: (A) control group; (B) 
diabetic group; (C) diabetic-PTFe group; (D) diabetic-PTFe+HDDM group where the region of the bone defect is replaced in 
most areas by a more intensively radiopaque image when compared to that of the normal surrounding bone (arrows).
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analysis. The optical density results were submitted 
to analysis of variance (ANOVA). The Tukey test 
was applied at a 5% significant level. A uniformity 
in the progression of the optical density averages in 
the Diabetic, D-PTFe and D-PTFe+HDDM groups 
was not observed (Table 1). We observed that there 
was a discrete decrease in optical density at 30 and 60 
days in the diabetic group, and at 60 days in the D-
PTFe group. However, the optical density averages in 
the D-PTFe+HDDM group showed the same radio-
graphic features in all observation times of this study. 
At 15 days, significant differences in optical densi-
ty were observed between the C and D-PTFe+HDDM 
groups (p < 0.05), the D and D-PTFe+HDDM 
groups, and the D-PTFe and D-PTFe+HDDM 
groups (p < 0.01). At 30 and 60 days, the D and 
D-PTFe+HDDM groups presented statistically sig-
nificant optical density differences (p < 0.01). At 90 
days, the C and D-PTFe+HDDM groups, the D and 
D-PTFe+HDDM groups, and the D-PTFe and D-
PTFe+HDDM groups also presented significant dif-
ferences in relation to optical density (p < 0.001).
Discussion
During our review of the literature, no work 
was found using HDDM in diabetic patients. It is 
known, however, that many chronic complications 
of Diabetes mellitus patients are related to changes 
in bone metabolism, since it may impair the bone 
repair process.5,9
In the last years, researchers have added growth 
factors to occlusive barriers such as insulin growth 
factor, growth factor related to platelets, and bone 
morphogenetic proteins, among others,4,10 to ac-
celerate the bone repair process. Some authors re-
ported the presence of these growth factors in bone 
matrix and dentin matrix, which can explain their 
osteoinductive activity.10-12
During all observation periods of the control 
group, an average optical density that increased 
gradually and progressively (Table 1) was observed. 
Moreover, it was noticed that the PTFe barrier pro-
moted an osteoconduction property, which influ-
enced bone growth positively. These findings were 
also observed by Abreu et al.1 (2004), Carvalho et 
al.2 (2004) and Gomes et al.3,4 (2001, 2002). How-
ever, a noticeable fact in all the diabetic groups was 
the discrepant variation in mean optical density 
values, especially after the 30- and 60-day periods, 
with an intense decrease in optical density. This fact 
could be explained by the occurrence of chronic 
complications in our experiment caused by constant 
hyperglycemia, which was often difficult to be con-
trolled, even using daily human insulin. 
In all periods, it was observed that the diabet-
ic-PTFe+HDDM group presented a significant in-
crease in average optical density when compared 
to the other groups studied (Table 1). After the 15-
day period, a not statistically significant decrease 
in optical density in the diabetic groups and in the 
diabetic-PTFe groups was observed when com-
pared with the control group. At 90 days, the group 
treated with HDDM presented a significant increase 
in optical density when compared with the con-
trol, diabetic, and diabetic-PTFe groups (p < .001) 
(Table 1). Moreover, the radiopaque images in the 
region of the bone defects implanted with HDDM 
were radiographically more homogeneous in all of 
their extension and after every observation period, 
when compared to the other groups studied. These 
findings were also observed by Abreu et al.1 (2004). 




(C, n = 12)
Diabetic 
(D, n = 12)
Diabetic-PTFe
(D-PTFe, n = 12)
Diabetic-PTFe+HDDM
(D-PTFe+HDDM, n = 12)
15  33.33 ± 3.42* 27.70 ± 1.30  30.63 ± 6.00  71.70 ± 16.50**
30  36.22 ± 2.54 21.52 ± 1.61  38.55 ± 6.77  62.64 ± 16.51**
60  45.67 ± 8.36 23.33 ± 2.62  31.85 ± 3.55  63.04 ± 11.04**
90  50.51 ± 11.02 40.89 ± 6.24  56.37 ± 18.10  103.60 ± 24.86***
*p < 0.05 (C/D-PTFe+HDDM). **p < 0.01 (D-PTFe+HDDM/D-PTFe/D). ***p < 0.001 (D-PTFe+HDDM/C/D/D-
PTFe).
Table 1 - Optical 
Density of newly formed 
bone (Mean ± SD).
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there was biocompatibility of HDDM, considering 
its integration with the newly formed bone matrix 
during all observation periods and the absence of 
any bone tissue reaction image as suggested images 
of bone sequestrum, osteomyelitis or others. More-
over, it has been demonstrated that HDDM stimu-
lates bone tissue osteopromotion precociously and 
significantly, contributing to a more favorable pro-
gression of the bone regeneration process.3,4,13
Many advantages of HDDM became evident in 
the present study, confirming the possibility of its 
application in clinical dentistry, especially in im-
plantodontology and for intra-oral surgeries in Dia-
betes mellitus patients which, in general, present 
high risk of infection and an impaired bone repair 
process.
Conclusion
It was possible to conclude that homogenous 
demineralized dentin matrix (HDDM) was bio-
compatible with newly formed bone in diabetic rab-
bits. HDDM stimulated an increase in bone defect 
radiopacity, suggesting new bone formation, and 
improving an osteopromotion property during the 
bone regeneration process. There were statistically 
significant differences (p < .001) among the dia-
betic-PTFe+HDDM, control, diabetic and diabetic-
PTFe groups. 
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